Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden

被引:0
|
作者
Marcus Lind
Per-Olov Matsson
Ragnar Linder
Irene Svenningsson
Leif Jørgensen
Uffe J. Ploug
Helge Gydesen
Mozhgan Dorkhan
Sara Larsen
Gunnar Johansson
机构
[1] NU-Hospital Group,Department of Medicine
[2] University of Gothenburg,Department of Molecular and Clinical Medicine, Institute of Medicine
[3] Domnarvet VC,Research and Development Unit
[4] Pygargus,Department of Caring Sciences and Family Medicine
[5] Primary Health Care,undefined
[6] Närhälsan,undefined
[7] IMS Health,undefined
[8] Novo Nordisk A/S,undefined
[9] Novo Nordisk Scandinavia AB,undefined
[10] Uppsala University,undefined
来源
Diabetes Therapy | 2016年 / 7卷
关键词
Liraglutide; Real-world evidence; Sitagliptin; Sweden; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:321 / 333
页数:12
相关论文
共 50 条
  • [1] Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden
    Lind, Marcus
    Matsson, Per-Olov
    Linder, Ragnar
    Svenningsson, Irene
    Jorgensen, Leif
    Ploug, Uffe J.
    Gydesen, Helge
    Dorkhan, Mozhgan
    Larsen, Sara
    Johansson, Gunnar
    [J]. DIABETES THERAPY, 2016, 7 (02) : 321 - 333
  • [2] A Retrospective Database Study of Liraglutide Persistence Associated with Glycemic and Body Weight Control in Patients with Type 2 Diabetes
    Cheli Melzer-Cohen
    Gabriel Chodick
    Lise Lotte N. Husemoen
    Nicolai Rhee
    Varda Shalev
    Avraham Karasik
    [J]. Diabetes Therapy, 2019, 10 : 683 - 696
  • [3] A Retrospective Database Study of Liraglutide Persistence Associated with Glycemic and Body Weight Control in Patients with Type 2 Diabetes
    Melzer-Cohen, Cheli
    Chodick, Gabriel
    Husemoen, Lise Lotte N.
    Rhee, Nicolai
    Shalev, Varda
    Karasik, Avraham
    [J]. DIABETES THERAPY, 2019, 10 (02) : 683 - 696
  • [4] Persistence to Liraglutide Therapy Is Associated with Good Glycemic and Body Weight Control in Patients with Type 2 Diabetes
    Cohen, Cheli Melzer
    Chodick, Gabriel
    Husemoen, Lise Lotte N.
    Rhee, Nicolai
    Shalev, Varda
    Karasik, Avraham
    [J]. DIABETES, 2018, 67
  • [5] Clinical and Genetic Predictors of Glycemic Control and Weight Loss Response to Liraglutide in Patients with Type 2 Diabetes
    Kyriakidou, Artemis
    Kyriazou, Angeliki, V
    Koufakis, Theocharis
    Vasilopoulos, Yiannis
    Grammatiki, Maria
    Tsekmekidou, Xanthippi
    Avramidis, Iakovos
    Baltagiannis, Stefanos
    Goulis, Dimitrios G.
    Zebekakis, Pantelis
    Kotsa, Kalliopi
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (03):
  • [6] A Combination Therapy with Liraglutide and Sitagliptin Improves Glycemic Control in Japanese Patients with Type 2 Diabetes Mellitus
    Matsuhashi, Yuki
    Chikazawa, Shinji
    Osonoi, Shou
    Mizushiri, Satoru
    Yamaichi, Masato
    Otaka, Hideyuki
    Takahashi, Kazuhisa
    Kanba, Aya
    Matsumura, Koki
    Matsuki, Kota
    Sato, Eri
    Tanabe, Jutaro
    Yanagimachi, Miyuki
    Murakami, Hiroshi
    Daimon, Makoto
    [J]. DIABETES, 2017, 66 : A629 - A629
  • [7] Combination of liraglutide and sitagliptin therapy improves glycemic control in Japanese patients with type 2 diabetes mellitus
    Matsuhashi, Yuki
    Chikazawa, Shinji
    Otaka, Hideyuki
    Takahashi, Kazuhisa
    Kabma, Aya
    Matsumura, Koki
    Matsuki, Kota
    Sato, Eri
    Tanabe, Jutaro
    Yanagimachi, Miyuki
    Murakami, Hiroshi
    Daimon, Makoto
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S101 - S101
  • [8] Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
    Mirabelli, Maria
    Chiefari, Eusebio
    Caroleo, Patrizia
    Arcidiacono, Biagio
    Corigliano, Domenica Maria
    Giuliano, Stefania
    Brunetti, Francesco Saverio
    Tanyolac, Sinan
    Foti, Daniela Patrizia
    Puccio, Luigi
    Brunetti, Antonio
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (01)
  • [9] Impact of UK guidelines on clinical prescribing in patients with Type 2 diabetes: a comparative effectiveness analysis of liraglutide vs sitagliptin in the UK
    McEwan, P.
    Evans, M. L.
    Nyeland, M. E.
    Skovgaard, R.
    Richards, A.
    Bergan, E. Q.
    Demuth, D.
    Alvarez, L. Garcia
    Muthutantri, A.
    Ploug, U. J.
    [J]. DIABETIC MEDICINE, 2014, 31 : 174 - 174
  • [10] Effect of sitagliptin on glycemic control in patients with type 2 diabetes
    Rahmah, Abbas Mahdi
    [J]. WORLD FAMILY MEDICINE, 2015, 13 (06): : 20 - 25